Senate, October 30, 2023 -- The committee on Health Care Financing, to whom was referred the petitions (accompanied by bill, Senate, No. 732) of John J. Cronin for legislation to promote comprehensive transparency in the pharmaceutical industry; (accompanied by bill, Senate, No. 749) of Cindy F. Friedman, Rebecca L. Rausch, Susannah M. Whipps, Joanne M. Comerford and other members of the General Court for legislation relative to pharmaceutical access, costs and transparency; (accompanied by bill, Senate, No. 767) of Jason M. Lewis for legislation to define modest meals and refreshments in prescriber education settings; (accompanied by bill, Senate, No. 778) of Paul W. Mark for legislation to bring down the cost of prescription drugs; (accompanied by bill, Senate, No. 783) of Mark C. Montigny and Michael J. Barrett for legislation to promote transparency and prevent price gouging of pharmaceutical drug prices; (accompanied by bill, Senate, No. 784) of Mark C. Montigny for legislation relative to coverage for chronic illness; (accompanied by bill, Senate, No. 797) of Jacob R. Oliveira for legislation to bring down the cost of prescription drugs; (accompanied by bill, House, No. 619) of Nicholas A. Boldyga relative to establishing a prescription drug rebate program for seniors; (accompanied by bill, House, No. 1176) of Edward F. Coppinger and others relative to promoting comprehensive transparency in the pharmaceutical industry; (accompanied by bill, House, No. 1201) of Kate Hogan relative to the pricing of prescription drugs; (accompanied by bill, House, No. 1205) of Bradley H. Jones, Jr., and others that the Health Policy Commission and health insurers create listings of certain high cost prescription drugs and that the Attorney General require drug manufacturers to provide information to justify increases in costs; (accompanied by bill, House, No. 1206) of Bradley H. Jones, Jr., and others for an investigation by a special commission (including members of the General Court) relative to contracts between the MassHealth program and pharmaceutical benefit managers; (accompanied by bill, House, No. 1215) of John J. Lawn, Jr., and others relative to pharmacy benefit managers; (accompanied by bill, House, No. 1246) of William M. Straus relative to drug prices paid by carriers; and (accompanied by bill, House, No. 1247) of Alyson M. Sullivan-Almeida, Michael J. Soter and David F. DeCoste relative to pharmacy benefit managers reimbursements to pharmacies in the Commonwealth, reports the accompanying bill (Senate, No. 2492).
Sponsored bills
By Representative Soter of Bellingham, a petition (accompanied by bill, House, No. 2954) of Michael J. Soter and others relative to property taxes for 100% disabled veterans. Revenue.
Maddy summaryThis bill grants property tax exemptions to disabled veterans in Massachusetts who have a service-connected disability rating of 100 percent from the U.S. Department of Veterans Affairs. To qualify, the veteran must be at least 65 years old, a legal resident of the state, and have served under honorable conditions, while the property must be their primary residence. The exemption covers a percentage of the home's value equal to the veteran's disability rating, with the state covering the resulting tax loss by reimbursing local municipalities. Additionally, the benefit extends to the surviving spouse if they continue to own and occupy the home after the veteran passes away.
Maddy summaryThis bill creates a special commission to examine the contracts between MassHealth, the state's health insurance program for low-income residents, and pharmaceutical benefit managers. The commission will evaluate whether MassHealth should switch from its current drug purchasing model to a pass-through model, which would allow pharmacies to negotiate prices directly with drug manufacturers. The ten-member panel includes state officials, legislative leaders, and representatives appointed by the governor to advocate for both pharmaceutical benefit managers and pharmacies. Within one year of the bill's passage, the commission must submit its findings and any proposed legislation to relevant state committees.
Maddy summaryThis bill requires Massachusetts' MassHealth program and large health insurers to annually publish lists of prescription drugs that have seen significant price increases, specifically those with costs rising by 50% over five years or 15% in the last year. The Attorney General will then select up to 15 of the most expensive drugs from these lists and mandate that manufacturers provide detailed documentation justifying the price hikes. Additionally, the bill establishes a regulatory framework with penalties for non-compliance and requires the Attorney General to report findings to the legislature each December.
By Representative Durant of Spencer, a petition (subject to Joint Rule 12) of Peter J. Durant and others relative to eligibility for the emergency housing assistance program. Housing.
Maddy summaryThis bill, introduced by Representative James K. Hawkins, aims to update regulations regarding the use of pesticides in Massachusetts. It directly affects agricultural operations, pest control companies, and individuals who apply chemical treatments to manage insects or weeds. The legislation seeks to establish clearer standards for pesticide application, storage, and disposal to ensure public safety and environmental protection. By modernizing existing rules, the bill intends to provide a more robust framework for managing chemical substances across the state.
Maddy summaryThis bill authorizes the state comptroller to move up to $10,000,000 annually from the Race Horse Development Fund to the Community Preservation Trust Fund. The transfer can only happen if the secretary of administration and finance submits a written request each fiscal year. This change would redirect money originally set aside for horse racing development toward community preservation projects.